Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CREBBP | Q92793 | 2/20 | 0.54 |
| ▸ | SRD5A1 | P18405 | 4/20 | 0.49 |
| ▸ | SRD5A2 | P31213 | 4/20 | 0.49 |
| ▸ | FABP4 | P15090 | 2/20 | 0.48 |
| ▸ | FABP5 | Q01469 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | CYSLTR2 | Q9NS75 | 1/20 | 0.46 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.46 |
| ▸ | CNR2 | P34972 | 5/20 | 0.46 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.45 |
| ▸ | CNR1 | P21554 | 5/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8959788 | 1.00 | CREBBP (0.54) | CREBBPSRD5A1SRD5A2FABP4FABP5 | |
| SCHEMBL8959940 | 0.89 | CNR2 (0.52) | CREBBPSRD5A1SRD5A2ALDH1A1SMN1; SMN2 | |
| SCHEMBL8959934 | 0.89 | CNR2 (0.52) | CREBBPSRD5A1SRD5A2ALDH1A1SMN1; SMN2 | |
| SCHEMBL8959613 | 0.88 | SRD5A1 (0.59) | CREBBPSRD5A1SRD5A2ALDH1A1SMN1; SMN2 | |
| SCHEMBL8959617 | 0.88 | SRD5A1 (0.59) | CREBBPSRD5A1SRD5A2ALDH1A1SMN1; SMN2 | |
| SCHEMBL8960132 | 0.80 | CNR2 (0.54) | CREBBPCNR2CNR1 | |
| SCHEMBL8959961 | 0.80 | CNR2 (0.54) | CREBBPCNR2CNR1 | |
| SCHEMBL8959785 | 0.80 | CNR2 (0.54) | CREBBPCNR2CNR1 | |
| SCHEMBL8960139 | 0.80 | CNR2 (0.54) | CREBBPCNR2CNR1 | |
| SCHEMBL8959955 | 0.80 | CNR2 (0.54) | CREBBPCNR2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5530019-A | FOR TREATMENT OF PROSTATE GLAND DISORDERS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-06-25 | — | — | US | disclosed |